Take advantage of the fastest-growing clinical trials region to accelerate your global clinical research.
Canada is a highly developed nation with one of the largest economies in the world. It performs strongly in international comparisons of quality of life, health, education, and other measures.
Canada is home to some of the world's best medical researchers and health professionals and enjoys world-class research infrastructure equal to the US. Clinical trial capability is also of an international standard and the country is well suited to conduct complex trials that are generally focused on indications aligned with the standard of care in developed nations.
With streamlined regulatory requirements and the supportive R&D Government refund of up to 30.6% on clinical research spend, Canada has become a preferred destination for all phases of clinical trials.
Greenline Clinical Research has built strong expertise over the years in providing CRO services to biotechnology companies in Canada.
In Canada, biotechnology companies enjoy start-up timelines of around 6 to 8 weeks, from Ethics Committee (EC) submission to Health Canada approval.
Receive a timely response to an enquiry about a service, process or technical questions.
